[ FDA DRUG SHORTAGES TRACKER ]

A drug shortage is a quality failure with a body count.

Live FDA drug shortage data (openFDA), grouped by status, availability, and therapeutic area. The FDA’s own root-cause analysis puts manufacturing and quality problems at the centre of the shortage crisis — which is why SPEQ treats the shortage list as a quality-system signal, not just a supply-chain one.

1,000
Active shortages tracked
852
Current
147
To be discontinued
212
Flagged unavailable
21% flagged unavailable · latest update 2026-07-30 · source: openFDA drug/shortages
NEW SHORTAGES POSTED · MONTHLY

By initial FDA posting date. openFDA lists active shortages, so older cohorts thin as entries resolve.

ACTIVE SHORTAGES BY THERAPEUTIC CATEGORY · TOP 10
WHY THIS SITS UNDER QUALITY, NOT LOGISTICS

The FDA’s 2019 report Drug Shortages: Root Causes and Potential Solutions found the dominant drivers are not scarcity of raw materials but a lack of incentives to produce, and manufacturing/quality problems that force production to stop. Mature quality systems — the difference a QMM assessment measures — are what keep a line running.

The economics of quality →FDA QMM framework →
Reset
1,178 matching shortages
DrugCompanyTherapeutic areaAvailabilityStatusPosted
Nebivolol Hydrochloride TabletTabletTorrent Pharmaceuticals LimitedCardiovascular—To Be Discontinued2026-03-25
Nebivolol Hydrochloride TabletTabletTorrent Pharmaceuticals LimitedCardiovascular—To Be Discontinued2026-03-25
Nebivolol Hydrochloride TabletTabletTorrent Pharmaceuticals LimitedCardiovascular—To Be Discontinued2026-03-25
Ivabradine Hydrochloride TabletTabletAmgen Inc.Cardiovascular—To Be Discontinued2026-03-24
Pilocarpine Hydrochloride Ophthalmic SolutionOphthalmic SolutionAbbVie Inc.Ophthalmology—To Be Discontinued2026-03-24
Ivabradine SolutionSolutionAmgen Inc.Cardiovascular—To Be Discontinued2026-03-24
Ivabradine Hydrochloride TabletTabletAmgen Inc.Cardiovascular—To Be Discontinued2026-03-24
Pentamidine Isethionate InjectionInjectionXGen Pharmaceuticals DJB, Inc.Anti-Infective—To Be Discontinued2026-03-23
Ramelteon TabletTabletTakeda Pharmaceuticals USA Inc.Psychiatry—To Be Discontinued2026-03-19
Ramelteon TabletTabletTakeda Pharmaceuticals USA Inc.Psychiatry—To Be Discontinued2026-03-19
Plerixafor InjectionInjectionFresenius Kabi USA, LLCHematology—To Be Discontinued2026-03-13
Peritoneal Dialysis SolutionSolutionFresenius Medical Care North AmericaRenal—To Be Discontinued2026-03-10
Peritoneal Dialysis SolutionSolutionFresenius Medical Care North AmericaRenal—To Be Discontinued2026-03-10
Peritoneal Dialysis SolutionSolutionFresenius Medical Care North AmericaRenal—To Be Discontinued2026-03-10
Peritoneal Dialysis SolutionSolutionFresenius Medical Care North AmericaRenal—To Be Discontinued2026-03-10
Peritoneal Dialysis SolutionSolutionFresenius Medical Care North AmericaRenal—To Be Discontinued2026-03-10
Peritoneal Dialysis SolutionSolutionFresenius Medical Care North AmericaRenal—To Be Discontinued2026-03-10
Everolimus TabletTabletTeva Pharmaceuticals USA, Inc.Transplant—To Be Discontinued2026-03-02
Everolimus TabletTabletTeva Pharmaceuticals USA, Inc.Transplant—To Be Discontinued2026-03-02
Everolimus TabletTabletTeva Pharmaceuticals USA, Inc.Transplant—To Be Discontinued2026-03-02
Everolimus TabletTabletTeva Pharmaceuticals USA, Inc.Transplant—To Be Discontinued2026-03-02
Itraconazole CapsuleCapsuleJanssen PharmaceuticalsAnti-Infective—To Be Discontinued2026-02-27
Itraconazole CapsuleCapsuleJanssen PharmaceuticalsAnti-Infective—To Be Discontinued2026-02-27
Itraconazole CapsuleCapsuleJanssen PharmaceuticalsAnti-Infective—To Be Discontinued2026-02-27
Clindamycin Palmitate Hydrochloride InjectionInjectionAmneal PharmaceuticalsAnti-Infective—To Be Discontinued2026-02-27
Page 40 of 48
← PrevNext →

Data: U.S. FDA openFDA drug/shortages API, which lists activeshortages (Current or To Be Discontinued) — it carries no per-record cause field, so SPEQ makes no root-cause claim on individual drugs; the quality framing above is cited FDA context. openFDA publishes shortage data for drugs only; SPEQ’s cross-industry coverage lives in the recall Explorer(drug, device & food).